Anaptysbio (ANAB) Free Cash Flow (2016 - 2026)
Anaptysbio (ANAB) posted Free Cash Flow of -$25.9 million for Q1 2026, down 126.49% on a QoQ basis from $97.9 million in Q4 2025, and down 142.14% year-over-year from $61.5 million in Q1 2025.
Anaptysbio (ANAB) Free Cash Flow (2016 - 2026) Analysis & Trends
Anaptysbio's Free Cash Flow history runs 11 years deep, the most recent figure standing at -$25.9 million for Q1 2026.
- Quarterly Free Cash Flow fell 142.14% year-over-year to -$25.9 million in Q1 2026, while the trailing twelve-month figure through Mar 2026 was $4.4 million (up 104.03% YoY) and the FY2025 annual result came in at $19.6 million, up 114.49% from the prior year.
- Free Cash Flow was -$25.9 million for Q1 2026 at Anaptysbio, down from $97.9 million in the prior quarter.
- Across five years, Free Cash Flow topped out at $97.9 million in Q4 2025 and bottomed at -$66.7 million in Q4 2024.
- A 5-year average of -$19.8 million and a median of -$24.7 million in 2023 frame the typical range for Free Cash Flow.
- Annual changes were most pronounced in 2022 — Free Cash Flow sank 376.03% — and 2025, when it soared 246.85%.
- Anaptysbio's Free Cash Flow stood at -$10.8 million in 2022, then plunged by 220.31% to -$34.6 million in 2023, then sank by 92.54% to -$66.7 million in 2024, then surged by 246.85% to $97.9 million in 2025, then plunged by 126.49% to -$25.9 million in 2026.
- Business Quant data shows ANAB's Free Cash Flow at -$25.9 million in Q1 2026, $97.9 million in Q4 2025, and -$27.3 million in Q3 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Free Cash Flow (Qtr) |
|---|---|---|---|---|---|
| 1 | Oculis Holding AG | 68,785.72 Bn | 68,785.72 Bn | - | -19.58 Mn |
| 2 | Nanobiotix | 1,895.57 Bn | 1,895.51 Bn | - | - |
| 3 | BeOne Medicines | 471.35 Bn | 466.56 Bn | 1.35 Bn | 158.09 Mn |
| 4 | NuCana | 279.75 Bn | 279.75 Bn | - | -1.53 Mn |
| 5 | Vertex Pharmaceuticals | 120.24 Bn | 113.00 Bn | 2.59 Bn | 1.29 Bn |
| 6 | Regeneron Pharmaceuticals | 67.80 Bn | 59.04 Bn | 3.31 Bn | 848.30 Mn |
| 7 | Belite Bio | 62.51 Bn | 62.51 Bn | - | - |
| 8 | Argenx Se | 57.38 Bn | 57.38 Bn | 1.41 Bn | - |
| 9 | Revolution Medicines | 37.78 Bn | 37.78 Bn | - | -354.95 Mn |
| 10 | Anaptysbio | 1.58 Bn | 1.29 Bn | - | -25.94 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -25.94 Mn |
| Mar 31, 2026 | -25.94 Mn |
| Dec 31, 2025 | 97.91 Mn |
| Dec 31, 2025 | 97.91 Mn |
| Sep 30, 2025 | -27.28 Mn |
| Sep 30, 2025 | -27.28 Mn |
| Jun 30, 2025 | -40.31 Mn |
| Jun 30, 2025 | -40.31 Mn |
| Mar 31, 2025 | -10.71 Mn |
| Mar 31, 2025 | -10.71 Mn |
| Dec 31, 2024 | -66.68 Mn |
| Dec 31, 2024 | -66.68 Mn |
| Sep 30, 2024 | -10.03 Mn |
| Sep 30, 2024 | -10.03 Mn |
| Jun 30, 2024 | -21.36 Mn |
| Jun 30, 2024 | -21.36 Mn |
| Mar 31, 2024 | -37.28 Mn |
| Mar 31, 2024 | -37.28 Mn |
| Dec 31, 2023 | -34.63 Mn |
| Dec 31, 2023 | -34.63 Mn |